ADAP
Adaptimmune Therapeutics
ADAP
ADAP
64 hedge funds and large institutions have $27.7M invested in Adaptimmune Therapeutics in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
0.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
9
Reduced
19
Closed
12
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$8K
